Tokuyama Corporation
Tokuyama Corporation (TKYMF) Financial Performance & Income Statement Overview
Review Tokuyama Corporation (TKYMF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Tokuyama Corporation (TKYMF) Income Statement & Financial Overview
View the income breakdown for Tokuyama Corporation TKYMF across both annual and quarterly reports.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $89.69B | $87.85B | $83.01B | $82.52B |
| Cost of Revenue | $61.01B | $60.74B | $57.50B | $55.67B |
| Gross Profit | $28.67B | $27.10B | $25.51B | $26.86B |
| Gross Profit Ratio | $0.32 | $0.31 | $0.31 | $0.33 |
| R&D Expenses | $0.00 | $3.93B | $0.00 | $3.95B |
| SG&A Expenses | $19.78B | $19.99B | $19.05B | $19.35B |
| Operating Expenses | $19.78B | $19.99B | $19.05B | $19.35B |
| Total Costs & Expenses | $80.79B | $80.74B | $76.56B | $75.02B |
| Interest Income | $97.00M | $0.00 | $61.00M | $55.00M |
| Interest Expense | $246.00M | $0.00 | $216.00M | $221.00M |
| Depreciation & Amortization | $5.06B | $4.42B | $4.82B | $4.42B |
| EBITDA | $12.39B | $11.54B | $10.20B | $11.93B |
| EBITDA Ratio | $0.14 | $0.13 | $0.12 | $0.14 |
| Operating Income | $8.90B | $7.11B | $6.46B | $7.50B |
| Operating Income Ratio | $0.10 | $0.08 | $0.08 | $0.09 |
| Other Income/Expenses (Net) | -$1.93B | $434.00M | -$1.29B | $4.14B |
| Income Before Tax | $6.97B | $7.55B | $5.16B | $11.64B |
| Income Before Tax Ratio | $0.08 | $0.09 | $0.06 | $0.14 |
| Income Tax Expense | $522.00M | $2.12B | $1.03B | $4.37B |
| Net Income | $6.47B | $5.28B | $4.24B | $7.40B |
| Net Income Ratio | $0.07 | $0.06 | $0.05 | $0.09 |
| EPS | $89.93 | $73.35 | $58.92 | $102.88 |
| Diluted EPS | $89.93 | $73.35 | $58.92 | $102.88 |
| Weighted Avg Shares Outstanding | $71.94M | $71.94M | $71.94M | $71.95M |
| Weighted Avg Shares Outstanding (Diluted) | $71.94M | $71.94M | $71.94M | $71.95M |
The company's financials show resilient growth, with revenue advancing from $82.52B in Q1 2024 to $89.69B in Q4 2024. Gross profit remained healthy with margins at 32% in Q4 2024 compared to 33% in Q1 2024. Operating income hit $8.90B last quarter, sustaining a consistent 10% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $12.39B. Net income rose to $6.47B, while earnings per share reached $89.93. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan